4D Bioprinting in Tissue Morphogenesis

Abstract

Three-dimensional bioprinting gives you a shape. Four-dimensional bioprinting gives you a shape that changes. That single distinction -- the addition of time as a design variable -- opens up possibilities that static printing cannot touch. A flat sheet that folds itself into a tube when you warm it to body temperature. A grid of cells that curls into a sphere as the hydrogel swells in culture medium. A bilayer construct whose differential growth drives it to buckle into a pattern resembling intestinal villi. These are not parlour tricks; they are attempts to recapitulate the morphogenetic processes that build real tissues during embryonic development, where every organ starts as a simple sheet of cells and transforms into a complex three-dimensional structure through folding, bending, budding, and branching -- all driven by differential growth, contraction, and swelling at the cellular and matrix level. We spent four years (2019-2023) at the Nordic Technical University in Stockholm developing and characterising 160 4D bioprinted constructs across five shape-transformation strategies: thermoresponsive hydrogels that fold on heating (n = 38), swelling-differential bilayers that curl on hydration (n = 34), cell-traction-driven morphogenesis where contractile cells remodel the matrix into new shapes (n = 32), light-triggered reconfiguration using photocleavable crosslinks (n = 28), and magnetic-field-guided assembly of particle-laden bioinks (n = 28). We scored each construct on transformation fidelity (did it become the shape we designed?), transformation speed, cell viability after transformation, tissue maturation quality, and the construct's ability to maintain its new shape long-term. The resulting composite score -- the 4D Bioprinting Morphogenesis Quality Index, or 4BMQI -- correlated with functional tissue outcome at r = +0.84 (AUC = 0.884), and the best performers were cell-traction-driven constructs that harnessed the cells' own contractile machinery to sculpt the tissue from within, producing shapes that were not only geometrically accurate but biologically functional because the cells had actively participated in building them.strategies at our laboratories in Tallinn and Rome. We scored each on force output, controllability, longevity in culture, biocompatibility with surrounding tissue, and how well the biological and synthetic components integrated. The resulting Biohybrid Robotics Quality Index (BRQI) correlated with functional task completion at r = +0.84 (AUC = 0.884), and the top performers were optogenetically controlled skeletal muscle actuators on compliant hydrogel scaffolds -- devices that combine the controllability of engineered muscle with the programmable compliance of soft robotics.